Quant Mutual Fund to shift focus from defensive to growth and cyclical stocks

In view of the fund’s overarching philosophy of leveraging periods of market pessimism to build positions in high-potential areas, Quant Mutual Fund is keen to move away from defensive exposure in their portfolios towards more cyclical & growth-oriented segments.

In a letter to their unit holders, Quant Mutual Fund has written, “In the coming weeks and months, we will begin pruning our defensive exposure toward more cyclical and growth-oriented segments. Allocations will gradually tilt in favour of very select high-beta names, particularly within the small-cap category, which are historically quicker to recover during market rebounds.”

“Such a strategy aligns with the fund’s overarching philosophy of leveraging periods of market pessimism to build positions in high-potential areas,” it adds.

Also Read: SIP vs Government Schemes: Where should you invest for a stress-free retirement?

The fund house says in the letter that “opportunity abounds not only at home but internationally as well. The US stands on the brink of a major transformative change under Trump’s leadership and the current cycle signifies a profound period of rebirth and reshaping of the very structures upon which the country was founded.”

“In this transformative era, the US may experience both disruptions and an opportunity for a renewed national identity under dynamic leadership, with the potential to evolve into an economy more reflective of its technological age and truly demonstrating the ideal of ‘American Exceptionalism’.”

“In such vibrant economic conditions, we continue to focus on building resilient portfolios through diversification, agility, superior risk, management, and delivering long-term values.”

Quant’s predictive analytics suggests a proactive approach to sectoral shifts within 2025 and an optimistic view of the broader economic environment.

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations